Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Bristol-Myers Squibb
Approval Status: Approved August 1997
Treatment for: Kaposi's Sarcoma

General Information

The U.S. Food and Drug Administration approved Bristol-Myers Squibb's cancer drug Taxol for the treatment of AIDS-related Kaposi's Sarcoma. Taxol therapy reduces the size of patients' tumors and diminishes their symptoms and pain. Taxol helped a majority of patients who had failed other therapies.